rs344550

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000064.4(C3):​c.4173-713G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.644 in 154,050 control chromosomes in the GnomAD database, including 32,037 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 31693 hom., cov: 32)
Exomes 𝑓: 0.58 ( 344 hom. )

Consequence

C3
NM_000064.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.457

Publications

18 publications found
Variant links:
Genes affected
C3 (HGNC:1318): (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]
C3 Gene-Disease associations (from GenCC):
  • atypical hemolytic-uremic syndrome with C3 anomaly
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen
  • complement component 3 deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Laboratory for Molecular Medicine
  • C3 glomerulonephritis
    Inheritance: AD Classification: MODERATE Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.93).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.682 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
C3NM_000064.4 linkc.4173-713G>C intron_variant Intron 33 of 40 ENST00000245907.11 NP_000055.2 P01024V9HWA9B4DR57

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
C3ENST00000245907.11 linkc.4173-713G>C intron_variant Intron 33 of 40 1 NM_000064.4 ENSP00000245907.4 P01024

Frequencies

GnomAD3 genomes
AF:
0.644
AC:
97948
AN:
151980
Hom.:
31672
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.645
Gnomad AMI
AF:
0.635
Gnomad AMR
AF:
0.638
Gnomad ASJ
AF:
0.579
Gnomad EAS
AF:
0.638
Gnomad SAS
AF:
0.703
Gnomad FIN
AF:
0.624
Gnomad MID
AF:
0.627
Gnomad NFE
AF:
0.648
Gnomad OTH
AF:
0.659
GnomAD4 exome
AF:
0.581
AC:
1135
AN:
1952
Hom.:
344
Cov.:
0
AF XY:
0.574
AC XY:
561
AN XY:
978
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.555
AC:
234
AN:
422
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.567
AC:
17
AN:
30
South Asian (SAS)
AF:
0.546
AC:
59
AN:
108
European-Finnish (FIN)
AF:
0.417
AC:
5
AN:
12
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.598
AC:
783
AN:
1310
Other (OTH)
AF:
0.529
AC:
37
AN:
70
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
23
47
70
94
117
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.644
AC:
98019
AN:
152098
Hom.:
31693
Cov.:
32
AF XY:
0.643
AC XY:
47820
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.645
AC:
26753
AN:
41462
American (AMR)
AF:
0.638
AC:
9745
AN:
15276
Ashkenazi Jewish (ASJ)
AF:
0.579
AC:
2006
AN:
3464
East Asian (EAS)
AF:
0.636
AC:
3297
AN:
5182
South Asian (SAS)
AF:
0.702
AC:
3389
AN:
4830
European-Finnish (FIN)
AF:
0.624
AC:
6599
AN:
10580
Middle Eastern (MID)
AF:
0.629
AC:
185
AN:
294
European-Non Finnish (NFE)
AF:
0.648
AC:
44074
AN:
67992
Other (OTH)
AF:
0.661
AC:
1394
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1846
3692
5539
7385
9231
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
798
1596
2394
3192
3990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.624
Hom.:
3683
Bravo
AF:
0.645
Asia WGS
AF:
0.672
AC:
2338
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.93
CADD
Benign
0.19
DANN
Benign
0.31
PhyloP100
-0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs344550; hg19: chr19-6682953; API